Ngā hua rapu - Ghaith Noaiseh
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial mā E. William St. Clair, Alan N. Baer, Wan‐Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K. Tarrant, Athena Papas, Valérie Devauchelle‐Pensec, Xue Wang, Wenjing Xu, Tuyet‐Hang Pham, Keith A. Sikora, William A. Rees, Ilias Alevizos
I whakaputaina 2024Artigo -
3
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome mā E. William St. Clair, Alan N. Baer, Chungwen Wei, Ghaith Noaiseh, A. L. Parke, Andreea Coca, Tammy O. Utset, Mark C. Genovese, Daniel J. Wallace, James McNamara, Karen Boyle, Lynette Keyes‐Elstein, Jeffrey L. Browning, Nathalie Franchimont, Kira Smith, Joel M. Guthridge, Igñacio Sanz, Judith A. James
I whakaputaina 2018Artigo -
4
Unique Sjögren’s syndrome patient subsets defined by molecular features mā Judith A. James, Joel M. Guthridge, Hua Chen, Rufei Lu, Rebecka L. Bourn, Krista Bean, Melissa E. Munroe, Miles Smith, Eliza Chakravarty, Alan N. Baer, Ghaith Noaiseh, Ann L. Parke, Karen Boyle, Lynette Keyes-Elstein, Andreea Coca, Tammy O. Utset, Mark C. Genovese, Virginia Pascual, Paul J. Utz, V. Michael Holers, Kevin D. Deane, Kathy L. Sivils, Teresa Aberle, Daniel J. Wallace, James McNamara, Nathalie Franchimont, E. William St. Clair
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Immunology
Internal medicine
Alternative medicine
Clinical endpoint
Gastroenterology
Pathology
Placebo
Rheumatism
Rheumatoid arthritis
Adipose tissue
Adverse effect
Anatomy
Ankle
Antibody
Autoantibody
Autoimmune disease
B cell
B-cell activating factor
Biochemistry
Bioinformatics
Biology
Body mass index
CXCL10
CXCL13
CXCL9
Chemistry
Chemokine
Chemokine receptor
Clinical trial